Carbinoxamine or rotoxamine
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313405This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 982A7M02H5, chemically known as pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)- but generally known as carbinoxamine, which bears US NIH Compound Identifier 2564. Carbinoxamine most often comes in base and maleate forms. European Medicines Agency schedules Carbinoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06128MIG. The term CARBINOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules carbinoxamine in its Anatomical Therapeutic Chemical (ATC) Classification. CARBINOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Carbinoxamine or rotoxamine bears US NLM identifiers UMLS ID C0054672 and NCI Concept Code C65286. SMILES: CLC1CCC(C(OCCN(C)C)C2NCCCC2)CC1.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.